Published in Psychosom Med on October 25, 2013
The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines. Int J Neuropsychopharmacol (2016) 0.79
The authors reply. Psychosom Med (2013) 0.75
ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med (2008) 2.18
Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr (2003) 2.89
Epileptic seizure following 1 Hz repetitive transcranial magnetic stimulation. Clin Neurophysiol (2006) 1.66
Investigating directed influences between activated brain areas in a motor-response task using fMRI. Magn Reson Imaging (2005) 1.61
Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain (2007) 1.42
Concerns about pregabalin: further experience with its potential of causing addictive behaviors. J Addict Med (2013) 1.28
Mechanisms and applications of theta-burst rTMS on the human motor cortex. Brain Topogr (2009) 1.17
Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol (2008) 1.17
Better risk assessment for individual substances. Dtsch Arztebl Int (2015) 1.09
Pregabalin abuse and dependence in Germany: results from a database query. Eur J Clin Pharmacol (2013) 1.09
Desomorphine goes "crocodile". J Addict Dis (2012) 1.08
Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Hum Brain Mapp (2009) 1.06
Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res (2003) 1.02
Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. J Psychiatry Neurosci (2011) 0.98
Side effects of transcranial magnetic stimulation biased task performance in a cognitive neuroscience study. Brain Topogr (2005) 0.95
Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp (2009) 0.94
Delusional infestation: neural correlates and antipsychotic therapy investigated by multimodal neuroimaging. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.93
Primary delusional parasitosis treated with olanzapine. Int Psychogeriatr (2007) 0.90
Cerebral Amyloidal Angiopathy--a disease with implications for neurology and psychiatry. Brain Res (2013) 0.88
Delusional parasitosis and the matchbox sign revisited: the international perspective. Acta Derm Venereol (2010) 0.88
Sensorimotor memory for fingertip forces during object lifting: the role of the primary motor cortex. Neuropsychologia (2007) 0.86
Spatial congruence of neuronavigated transcranial magnetic stimulation and functional neuroimaging. Clin Neurophysiol (2002) 0.86
Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology (Berl) (2002) 0.86
Cortical activation during a pitch discrimination task in tinnitus patients and controls--an fMRI study. Audiol Neurootol (2009) 0.85
Paliperidone extended-release: does it have a place in antipsychotic therapy? Drug Des Devel Ther (2011) 0.84
Sham or real--post hoc estimation of stimulation condition in a randomized transcranial magnetic stimulation trial. Neurosci Lett (2010) 0.83
Continuous theta-burst stimulation over the dorsal premotor cortex interferes with associative learning during object lifting. Cortex (2008) 0.82
Self-mutilation induced by psychotropic substances: a systematic review. Psychiatry Res (2012) 0.82
Ziprasidone in Parkinson's disease psychosis. Can J Psychiatry (2004) 0.82
Safety and tolerability of agomelatine: focus on hepatotoxicity. Curr Drug Metab (2014) 0.80
Low ceruloplasmin in a patient with Niemann-Pick type C disease. J Clin Neurosci (2012) 0.79
Aripiprazole and Parkinson's disease psychosis. Am J Psychiatry (2004) 0.79
Exploring the affective component of pain perception during aversive stimulation in borderline personality disorder. Psychiatry Res (2010) 0.79
Dependence on flupirtine. J Clin Pharmacol (2013) 0.78
"Krokodil":revival of an old drug with new problems. Subst Use Misuse (2012) 0.77
Safety of electroconvulsive therapy in the presence of cranial metallic objects. J ECT (2014) 0.77
Relationship between transitional objects and personality disorders in female psychiatric inpatients: a prospective study. J Pers Disord (2014) 0.76
Linking Annual Prescription Volume of Antidepressants to Corresponding Web Search Query Data: A Possible Proxy for Medical Prescription Behavior? J Clin Psychopharmacol (2015) 0.76
Somatization disorder treated with electroconvulsive therapy. J ECT (2011) 0.76
Altered time course of unconscious response priming in schizophrenia patients. Schizophr Res (2013) 0.75
[The PsychKHG in Baden-Württemberg: reduction of the rights of the mentally ill over the weekend?]. Psychiatr Prax (2015) 0.75
Tomophobia, the phobic fear caused by an invasive medical procedure - an emerging anxiety disorder: a case report. J Med Case Rep (2009) 0.75
Intoxications with the monoamine oxidase inhibitor tranylcypromine: an analysis of fatal and non-fatal events. Eur Neuropsychopharmacol (2013) 0.75
Electroconvulsive therapy and posttraumatic stress disorder: first experience with conversation-based reactivation of traumatic memory contents and subsequent ECT-mediated impairment of reconsolidation. J Neuropsychiatry Clin Neurosci (2014) 0.75
Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol. J Clin Psychopharmacol (2004) 0.75
Lack of Differentiation. Dtsch Arztebl Int (2017) 0.75
Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report. J Med Case Rep (2012) 0.75
Neuroleptic malignant syndrome with aripiprazole in Huntington's disease. Mov Disord (2010) 0.75
[Behavioural problems and personality change related to cerebral amyloid angiopathy]. Psychiatr Prax (2012) 0.75
Electroconvulsive therapy in the treatment of depression in a former ecstasy user. J Psychopharmacol (2006) 0.75
Performance of electroconvulsive therapy in a patient with clipping (Yasargil Titanium Clip) of an aneurysm of the internal carotid artery without vascular complications. Brain Stimul (2013) 0.75
Non-suicidal self-injury by intravenous application of nicotine in a patient with borderline personality disorder resulting in substance dependence. Addiction (2011) 0.75
Abuse liability of flupirtine revisited: implications of spontaneous reports of adverse drug reactions. J Clin Pharmacol (2013) 0.75
Depressive symptoms as first manifestation of posterior cortical atrophy. Am J Psychiatry (2006) 0.75
Cognitive impairment and abnormal behaviour related to ring chromosome 20 aberration. J Autism Dev Disord (2012) 0.75
Electroconvulsive therapy in patients with diagnoses other than major depression and/or difficult characteristics: a combined psychiatric-anesthesiological approach based on a retrospective chart analysis. Psychiatry Res (2013) 0.75
Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment. J ECT (2015) 0.75
Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole. J Clin Psychopharmacol (2004) 0.75
Self-inflicted testicular amputation in first lysergic acid diethylamide use. J Addict Med (2013) 0.75
First-Episode Psychosis Possibly due to Roxithromycin-Related Inhibition of Metabolization of Tetrahydrocannabinol. J Clin Psychopharmacol (2017) 0.75
Tranylcypromine discontinuation symptoms and withdrawal delirium. J Clin Psychopharmacol (2013) 0.75
Mania related to mesterolone in a previously mentally healthy person. J Clin Psychopharmacol (2012) 0.75